Fractional flow reserve vs angiography in non-ST- elevation myocardial infarction: long-term results of the FAMOUS-NSTEMI trial | European Heart Journal | Oxford Academic https://t.co/gPXnlSssil
As presented at the American Heart Association Conference 2025, patients with chest pain and without obstructive coronary artery disease benefit from treatment informed by cardiovascular magnetic resonance. https://t.co/plo1iHqVBS
Congratulations @ColinBerryMD and #CorCMR for demonstrating that CMR quantitative perfusion diagnosis of coronary microvascular dysfunction linked with medical therapy improves angina in pts with suspected #INOCA. I was honored to be a discussant #AHA25#LBCT#whycmr
From @JAMANetworkOpen: Among adults with symptoms after #COVID19 infection, a pragmatic, home-based resistance exercise program is a generalizable, safe, and effective therapy for improving both physical and psychological function.
#AHA25@AHAScience
https://t.co/vQ0BDWXNOt
CorCMR trial: Using stress CMR in angina patients without obstructive CAD reclassified diagnoses and led to improved symptoms and quality of life at 12 months compared to standard care. #AHA25 View the slides here: https://t.co/regGUnq1re
Microvascular angina is under diagnosed by coronary angiography. MRI improves diagnosing angina, symptoms and quality of life. 🙏 All credit to the participants and staff who supported the @TheBHF CorCMR trial https://t.co/5WUXPA5ixw @JubileeHospital@UofGlasgow@UofGMVLS
@ColinBerryMD & R. Hanna editorial on Nogami et al.’s study of >1,200 ANOCA patients.
Insights into how chest pain phenotypes relate to coronary microvascular dysfunction and prognosis.
🔗 https://t.co/Vfcn5atudt
#CardioTwitter#CMD#ANOCA
Main paper: https://t.co/rdcDoQuBYh
Well done to Dylan showcasing our work at #ESC2025 this year, on the use of machine learning to simplify complex coronary small vessel diagnostics
@ColinBerryMD@DanielTYAng@UofGSCMH
Intramyocardial hemorrhage after AMI is prognostically important and can be diagnosed by T2* CMR imaging. In clinical trials post-MI, T2* CMR imaging has potential as a risk stratifier and therapeutic target @ColinBerryMD@UofGlasgow@JubileeHospital https://t.co/rvpQo5dn7l
You can catch up on some sessions from #BCS2025 in our Digital Knowledge Hub 💡
There are currently three sessions available, with more to be added over the coming weeks:
✅ 2024 ESC Guidelines for the management of chronic coronary syndromes - ESC Perspective, Prof @alaide_chief
✅ 2024 ESC Guidelines for the management of chronic coronary syndromes - UK Perspective, Prof @ColinBerryMD
✅ BCS Lecture: The Maths of Life and Death, Prof @Kit_Yates_Maths
To watch, visit our https://t.co/locstbzG9a (you may need to create an account).
#DKH #cardiology #CardioEd #CardioTwitter #Education #Medical #MedicalEducation #HealthcareProfessional #HCP
In Session 3 our panel of experts, led by Professor Colin Berry, will discuss the mechanisms involved in INOCA, demystify CMD and Spasm, discussing CMR in diagnostics AND talking about the brain-heart connection in CMD
Register your interest early as we only have 10 places left!
In this analysis from 9 TTS cohorts, microvascular dysfunction in acute phase was assoc w/ all-cause mortality. An ⬆️ IMR, was the only independent predictor of both mortality & MACCE https://t.co/HwbhMCN1u9
#JACCINT@ColinBerryMD@RobEerdekens@GiovanniLuigiD1@_RobSykes